Jean-GabrielGriboul

Partner

Paris + 33.1.56.59.38.92

Connect:

Share

Jean-Gabriel Griboul has 20 years of experience advising clients on private and public M&A, private equity, and equity capital market (ECM) transactions, including domestic and cross-border acquisitions or investments, divestitures and strategic alliances, and corporate law issues.

He is recognized in numerous legal publications, including Chambers Europe that notes "his commercial sense is valued by clients, one dubbing him ‘efficient, precise and pragmatic’."

Jean-Gabriel represents listed and unlisted companies, their managers, as well as the private equity and corporate investors that finance them. He has acted as principal lawyer in a significant number of early to late-stage financing rounds (venture and growth capital; joint ventures), M&A transactions, initial public offerings (IPOs,) rights issues, tender offers, and private placements.

Recent transactions in which Jean-Gabriel has acted as lead lawyer include: M&A: several cross-border build-up acquisitions completed by Doctolib; the acquisition by Taranis Investments (Perenco Group) of the African project portfolio of Akuo Energy Afrique; the acquisition of Bimpli (BPCE) by Swile; and the sale of Linkfluence to Meltwater; private equity: Sanofi's investment in a biotech entity controlled by Orano Med; all financing rounds completed by Swile; Unseenlabs Series C financing round; and ADEME Investissement on the offshore floating wind development company created with BW Ideol; and capital markets: the Nasdaq IPO of Nanobiotix and the ChapsVision tender offer on Coheris.

Experience

  • Taranis Investment Limited, a Perenco group company, acquires Africa business of the Akuo GroupJones Day advised Taranis Investment Limited, a Perenco group company, in the acquisition of the African project portfolio from Akuo Energy Afrique, a renewable energy developer.
  • Ankaa Ventures leads Sepia Infrastructure first fundraisingJones Day advised Ankaa Ventures as a lead investor in the first fundraising for Sepia Infrastructure, a data center land and power provider that develops low-carbon energy solutions for the European industrial technology market.
  • Doctolib acquires Aaron.aiJones Day advised Doctolib, the leading healthtech company in Europe, in its acquisition of the Berlin company Aaron.ai, the current market leader in Germany for AI-based telephone assistance solutions for medical practices, relieving doctors and practice staff of answering telephone calls and offering patients telephone access to doctors' practices around the clock.
  • Swile and Groupe BPCE to combine to create global leader in employee benefitsJones Day advised Swile, a worktech unicorn, in the acquisition of Bimpli, a subsidiary of Groupe BPCE and leader in employee services and benefits in France.
  • Tikehau Capital, Wendel Growth, Definvest (Bpifrance), and 360 Capital sell their stakes in Preligens to SafranJones Day advised Tikehau Capital, Wendel Growth, Definvest (Bpifrance), and 360 Capital in the sale of their stakes in Preligens, a world leader in artificial intelligence (AI) for aerospace and defense, to Safran.
  • Euroclear invests in IZNESJones Day advised Euroclear in its investment in IZNES, a pan-European funds marketplace based on blockchain technology.
  • Unseenlabs raises €85 millionJones Day advised Unseenlabs, a France-based company and global leader in maritime surveillance through detection and geolocation of radio frequency signals from space, in its €85 million financing for significant expansion of observation capabilities, strengthening of international presence, consolidation of private sector activities, innovation of new products and solutions, and recruitment of new talents.
  • Quandela raises €50 millionJones Day advised Quandela, the European leader in photonic quantum computing, in raising €50 million from investors, the French government through the France 2030 Plan, and banking partners, allowing Quandela to expedite its international expansion and increase the production of its quantum computers to meet the needs of industrial clients.
  • Vibe.co raises $22.5 million in Series A fundingJones Day advised Vibe.co, an operator of a programmatic advertising space buying platform that enables brands to broadcast and run their own advertising campaigns on connected TVs and other applications that deliver video content, in its $22.5 million Series A funding led by Singular.
  • Swile raises $200 million in Series D financingJones Day advised Swile, a French-based tech company that offers digital solutions for employee rewards and benefits through a custom card and app, in connection with its $200 million Series D round of financing led by SoftBank, alongside existing investors Index Ventures, Eurazeo and Bpifrance Large Venture.
  • Illuminate Financial participates in $16 million Series A financing of GladiaJones Day advised Illuminate Financial in connection with its participation in the $16 million Series A financing of Gladia, a French AI software provider dedicated to artificial intelligence.
  • Société Generale, Demeter and ADEME participate in €35 million financing round of Qarnot ComputingJones Day advised Société Generale Ventures, Demeter and ADEME in connection with their participation in the €35 million financing round of Qarnot Computing, a French start-up using data centers and computers as heat source.
  • Adikteev bought out by managementJones Day advised Adikteev SA in the management buyout by Xavier Mariani and Emilien Eychenne as well as several other executives.
  • Elaia Partners, XAnge, and Bpifrance participate in €27 million Series B financing of GleamerJones Day advised Elaia Partners, XAnge, and Bpifrance in connection with the €27 million Series B financing of Gleamer, the leading European manufacturer in AI-powered solutions for medical imaging.
  • Portage and Orange Ventures lead €37 million Series C financing of MooncardJones Day advised Portage and Orange Ventures as lead investors in connection with the €37 million Series C financing of Mooncard, the French leader in the automation of corporate spend, in which historical investors Aglaé Ventures, BlackFin Capital Partners, Partech Partners and RAISE Ventures also participated.
  • Portage Ventures (Sagard) participates in €29 million funding round of AcheelJones Day represented Portage Ventures (Sagard) in the €29 million funding round of Acheel, a Paris, France based startup building a digital platform for selling non-life insurance products.
  • Nanobiotix completes $113.3 million IPO on NasdaqJones Day represented Nanobiotix S.A., a French clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, in connection with its $113.3 million initial public offering in the United States and listing on Nasdaq.
  • Debiopharm and M Ventures co-lead €15.5 million Series A financing of IktosJones Day advised Debiopharm Innovation Fund, M Ventures, and Omnes Capital in the €15.5 million Series A financing of Iktos, a company specializing in artificial intelligence for new drug discovery.
  • Snapshift raises $45 million in Series A roundJones Day advised Snapshift, the French SaaS HR application for businesses in the hospitality and retail sector, in its $45 million Series A financing round led by Highland Europe.
  • Elaia Partners and Hi Inov sell ForePaaS to OVHcloudJones Day advised Elaia Partners and Hi Inov in the sale of ForePaaS, a unified platform specializing in data analytics, machine learnings, and artificial intelligence projects for businesses, to OVHcloud, the European leader in cloud computing.
    • View All

    November 2018 Commentary

    Driverless, Networked Vehicles on the Rise, French Liability Regulations Lag Behind

    September 18-20, 2023 Speaking Engagements

    Jones Day lawyers to attend IPEM 2023

    Additional Speaking Engagements

    • 12 avril 2018
      Finale de la 4ème édition du Prix Jones Day/Paris II/ESSEC
    • 7 janvier 2016
      Le private equity : quelles opportunités pour 2016 ?

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.